Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Research, development and commercialization of therapeutic and product candidates6.7M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States23.46M70.11%
Europe10M29.89%